Oneness Biotech financials at a glance

+ Portfolio

The revenue of Oneness Biotech is reported as 0.07256 billion New Dollars in the fiscal year 2023. The earnings were -2.91 New Dollars per share in 2023, which was 463.75 lower than 2022. And about -2.47056 billion New Dollars are reported as free cash flow in the financials of Oneness Biotech 2023. Dividends of 0 New Dollars per share were paid to shareholders of Oneness Biotech stock TPEX:4743 in fiscal 2023.

NT$72.56M

Revenue

NT$-2.91

Earnings Per Share

37.52%

Gross Margin %

NT$-,993.00M

Free Cash Flow

Revenue

72.56

Earnings Per Share

-2.91

Gross Margin %

37.52

Free Cash Flow

-,993.00

Financials

Year	Year	TTM	2023	2022
Rev.	Revenue	N/A	NT$72.56M	NT$1.07B
GM %	Gross Margin %	36.20%	37.52%	79.24%
OM	Operating Margin	0.00%	0.00%	-22.66%
EPS	Earnings Per Share	NT$-3.28	NT$-2.91	NT$0.80
Div.	Dividends	N/A	NT$0.00	NT$0.00
PR %	Payout Ratio %	0	-0.00%	0
Sha.	Shares	N/AM	453.56M	443.85M
OCF	Operating Cash Flow	N/A	NT$-2,380.50M	NT$-,881.00M
FCF	Free Cash Flow	N/A	NT$-,993.00M	NT$-,968.35M
FCFS	Free Cash Flow Per Share	NT$-1.97	NT$-1.14	NT$-2.20

Oneness Biotech financials at a glance

Financials

Discover